Papers
2
Total Citations
33
H-Index
2
About
Dr. C. Nedelcu is a leading researcher in the field of urologic oncology, with a primary focus on the comparative effectiveness of minimally invasive treatments for renal cell carcinoma (RCC). Their work is centered on evaluating and optimizing therapeutic strategies for kidney tumors, particularly through the lens of thermal ablation and robotic-assisted surgery. Dr. Nedelcu’s major contributions include landmark comparative studies, such as the multicenter matched-pair analysis (AblatT1b study—UroCCR 80), which directly compared percutaneous tumor ablation to robotic-assisted partial nephrectomy for T1b RCC. This work, cited over 25 times, provides critical evidence on oncologic outcomes and morbidity trade-offs for intermediate-sized renal masses. By systematically analyzing 3D image-guided robotic approaches versus ablation techniques, Dr. Nedelcu has helped clarify optimal treatment pathways for patients with cT1b tumors, a challenging clinical scenario where partial nephrectomy remains the gold standard but ablation offers lower morbidity. Their research has been instrumental in advancing the evidence base for personalized, minimally invasive kidney cancer care, influencing both surgical and interventional radiology practices.
Research Focus
Key Achievements
Top Papers
- 1
- 2